Skip to main content
Clinical Trials/NCT05246904
NCT05246904
Completed
Not Applicable

Validating a Self-fitting Hearing Aid

University of Minnesota1 site in 1 country41 target enrollmentMarch 17, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hearing and Vision Loss
Sponsor
University of Minnesota
Enrollment
41
Locations
1
Primary Endpoint
Abbreviated profile of hearing aid benefit
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Eargo, Inc. has developed a hearing aid that contains self-fitting gain software that allows adults with mild-to-moderate hearing loss to test their hearing sensitivity and program hearing aids to match their measured hearing loss. Traditionally, hearing aids are custom programmed by a hearing health professional based on a professional hearing test. This technology has the potential to improve affordability and accessibility of hearing aids for adults with mild-to-moderate hearing loss. We propose to validate Eargo's self-fitting software in a clinical trial comparing self-fitting hearing aid outcomes to the same hearing aid fit by a professional following usual clinical best practice for fitting hearing aids.

Detailed Description

The study will recruit 30-50 adults age 18 and over with mild-to-moderate hearing loss in both ears. We will aim to recruit a sample with roughly equal number of males and females and new and experienced hearing aid users (defined by any hearing aid use within the previous 6 months). Hearing loss will be measured using the results of a standard clinical hearing test. We will use a within-subject, crossover design in which all participants will complete both field trial hearing aid conditions (self-fit and clinically fit hearing aids). The order of the field trials will be randomized across participants to account for any potential order effects. After each field trial, participants will visit the lab to complete study outcome measures, including hearing aid benefit, subjective sound quality, and speech in noise intelligibility testing.

Registry
clinicaltrials.gov
Start Date
March 17, 2022
End Date
February 28, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • mild to moderate hearing loss ability to follow written directions,

Exclusion Criteria

  • inability to use software during first visit

Outcomes

Primary Outcomes

Abbreviated profile of hearing aid benefit

Time Frame: 2-3 weeks

Survey of subjective benefit

Speech in noise test, AZ Bio sentences

Time Frame: Immediately after fitting

Sentence recognition test in background noise

Secondary Outcomes

  • Subjective sound quality rating(2-3 weeks)

Study Sites (1)

Loading locations...

Similar Trials